Global Nucleic Acid Aptamers Market Size Study, by Type (DNA Aptamer, RNA Aptamer, XNA Aptamer), by Application (Drug Delivery, Anti-viral Therapy, Pathogen Recognition, Disease Recognition, Stem Cell Markers, Others), by Indication (Viral Infection, Canc

Global Nucleic Acid Aptamers Market Size Study, by Type (DNA Aptamer, RNA Aptamer, XNA Aptamer), by Application (Drug Delivery, Anti-viral Therapy, Pathogen Recognition, Disease Recognition, Stem Cell Markers, Others), by Indication (Viral Infection, Cancer, Ophthalmology, Others), by End-user (Biopharmaceutical Companies, Diagnostic Centers, CROs, Others) and Regional Forecasts 2022-2032

The global industry was valued at USD 219.9 million in 2023 and is anticipated to grow with a healthy growth rate of more than 17.2% over the forecast period 2024-2032. Nucleic acid aptamers are emerging as a promising alternative to traditional antibodies due to their distinct advantages, including synthesis in vitro, favourable storage properties, and minimal immunogenicity in therapeutic applications like drug delivery and anti-viral therapy. Their high specificity and ability to recognize molecular targets make them comparable to antibodies, positioning them as a viable substitute in various biomedical applications.

The expanding recognition of the benefits of aptamers over antibodies, coupled with technological advancements and a growing spectrum of diseases, is driving the demand for nucleic acid aptamers. These molecules are increasingly being utilized as antimicrobial agents, particularly against biofilm-forming bacteria that exhibit significant resistance to conventional antibiotic treatments. This demand is further fuelled by the rising incidence of bacterial drug resistance and the need for innovative therapeutic approaches. Furthermore, the market is experiencing growth due to the enhanced awareness of aptamers' effectiveness in targeting small molecules and dyes, which is crucial for point-of-care diagnostics and conventional diagnostic kits. Aptamers' ability to bind with larger molecules, particularly proteins, makes them valuable in biomarkers and diagnostic applications, thereby boosting their market penetration. However, the market faces challenges such as a shortage of skilled professionals required for the development and application of aptamers. The complex processes involved in aptamer development demand technical expertise and advanced instrumentation, which can impede market growth.

In terms of regional analysis, North America dominated the market in 2023, attributed to favourable governmental recommendations, substantial R&D investments, and a well-developed healthcare infrastructure. The Asia Pacific region is expected to witness significant growth during the forecast period due to a rising pediatric population and governmental initiatives to combat the increasing prevalence of diseases.

Major market players included in this report are:

Aptamer Group

Raptamer Discovery Group

Soma-Logic

Aptamer Sciences

Aptagen

Maravai Lifesciences

Kaneka Corporation

Neo Ventures Biotechnology

Aptus Biochem

Base Pair Technologies

The detailed segments and sub-segment of the market are explained below:

By Type:
• DNA Aptamer
• RNA Aptamer
• XNA Aptamer

By Application:
• Drug Delivery
• Anti-viral Therapy
• Pathogen Recognition
• Disease Recognition
• Stem Cell Markers
• Others

By Indication:
• Viral Infection
• Cancer
• Ophthalmology
• Others

By End-user:
• Biopharmaceutical Companies
• Diagnostic Centers
• CROs
• Others

By Region:
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.